Coincident with the tsunami of COVID-19–related publications, there has been a surge of
studies using real-world data, including those obtained from the electronic health record (EHR)…

The rise of personalized medicine and the availability of high-throughput molecular analyses
in the context of clinical care have increased the need for adequate tools for translational …

De novo and inherited rare genetic disorders (RGDs) are a major cause of human morbidity,
frequently involving neuropsychiatric symptoms. Recent advances in genomic technologies …

We leveraged the largely untapped resource of electronic health record data to address critical
clinical and epidemiological questions about Coronavirus Disease 2019 (COVID-19). To …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver
disease worldwide. It affects an estimated 20% of the general population, based on cohort …

Objective To estimate the risk of acute myocardial infarction (AMI) or stroke in adults with
non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). Design …

Background While acute kidney injury (AKI) is a common complication in COVID-19, data
on post-AKI kidney function recovery and the clinical factors associated with poor kidney …

Objective The first year of university is a particularly stressful period and can impact academic
performance and students’ health. The aim of this study was to evaluate the health and …

The promise of precision medicine lies in data diversity. More than the sheer size of biomedical
data, it is the layering of multiple data modalities, offering complementary perspectives, …

The risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well characterized
in multi-national settings with appropriate controls. We leveraged electronic health record …